{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:52:27Z","timestamp":1773237147003,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.juro.2011.10.142","type":"journal-article","created":{"date-parts":[[2012,1,15]],"date-time":"2012-01-15T21:46:49Z","timestamp":1326664009000},"page":"868-871","source":"Crossref","is-referenced-by-count":28,"title":["Potential Years of Life Lost Due to Urogenital Cancer in the United States: Trends From 1972 to 2006 Based on Data From the SEER Database"],"prefix":"10.1097","volume":"187","author":[{"given":"Mohamed H.","family":"Kamel","sequence":"first","affiliation":[{"name":"Departments of Urology and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Page C.","family":"Moore","sequence":"additional","affiliation":[{"name":"Departments of Urology and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil K.","family":"Bissada","sequence":"additional","affiliation":[{"name":"Departments of Urology and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy M.","family":"Heshmat","sequence":"additional","affiliation":[{"name":"Departments of Urology and Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.10.142_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2011.10.142_bib2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jnci\/djn383","article-title":"Estimates and projections of value of life lost from cancer deaths in the United States","volume":"17","author":"Yabroff","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2011.10.142_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.cej.0000228408.68353.ba","article-title":"Cumulative cancer mortality risk and potential years of life lost to 64 years of age in Ireland, 1953\u20132002","volume":"16","author":"O'Lorcain","year":"2007","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.juro.2011.10.142_bib6","author":"Kochanek"},{"key":"10.1016\/j.juro.2011.10.142_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2105\/AJPH.79.11.1490","article-title":"Person-years of life lost due to cancer in the United States, 1970 and 1984","volume":"79","author":"Horm","year":"1989","journal-title":"AJPH"},{"key":"10.1016\/j.juro.2011.10.142_bib8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-5347(05)65640-6","article-title":"The changing natural history of renal cell carcinoma","volume":"166","author":"Pantuck","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.142_bib9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.urology.2005.07.009","article-title":"Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients","volume":"66","author":"Gudbjartsson","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.10.142_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.24685","article-title":"Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis","volume":"116","author":"Jonasch","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2011.10.142_bib11","first-page":"1516","article-title":"Urothelial tumors of the upper urinary tract","volume":"vol 2","author":"Sagolowski","year":"2011"},{"key":"10.1016\/j.juro.2011.10.142_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2004.05.006","article-title":"Germ cell tumours of the testis","volume":"53","author":"Gori","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.juro.2011.10.142_bib13","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.10.142_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","article-title":"Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma","volume":"76","author":"Abouassaly","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2011.10.142_bib15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.10.142_bib16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.10.142_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1464-410X.2010.10032.x","article-title":"Screening for prostate cancer: an updated Cochrane systematic review","volume":"107","author":"Ilic","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2011.10.142_bib18","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.23743","article-title":"Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003","volume":"15","author":"Hernandez","year":"2008","journal-title":"Cancer, suppl."}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711054656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711054656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.10.142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T18:55:44Z","timestamp":1713380144000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.10.142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1016\/j.juro.2011.10.142"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.10.142","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}